Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer

Stopped Study terminated due to reproducibility issues with genomics prediction model

Conditions

• Early-Stage Breast Cancer

Interventions

• DRUG: Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC)

Sponsor

Duke University

Collaborators

• [object Object]